Role of Genetic Analysis of Products of Conception and PGT in Managing Early Pregnancy Loss
(Abstracted from Reprod Biomed Online 2023;49(1):103738) Recurrent pregnancy loss (RPL), defined by 2 or more failed clinical pregnancies before 20 weeks’ gestation, affects 2% to 4% of reproductive-aged women worldwide. The recommended workup for RPL includes karyotypes in both partners, imaging of the uterine cavity, and testing for endocrine and autoimmune disorders; however, these evaluations result in an explanation for fewer than 45% of all patients.
Authors
- Ralph S. Papas (ORCID: https://orcid.org/0000-0002-1464-5809)
- Melissa Maisenbacher (ORCID: https://orcid.org/0000-0001-7907-2004)
- William H. Kutteh (ORCID: https://orcid.org/0000-0002-6049-3842)
- Elias M. Dahdouh (ORCID: https://orcid.org/0000-0002-7247-2731)
Institutions
- W&H (Austria) (AT)
- Dwight Englewood School (US)
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/ogx.0000000000001318
- Primary Topic
- Birth, Development, and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00